News
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China
InnoCare Pharma gets China NMPA approval to conduct clinical trial for a novel ADC ICP-B794 in China: Beijing Saturday, July 5, 2025, 11:00 Hrs [IST] InnoCare Pharma, a commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback